Neurology Devices Market Size, Share and Forecast 2019-2026

SKU: DMD364 | Last Updated On: Dec 05 2019 | No. of Pages: 186 | Available Formats

In July 2019, Penumbra introduced a new stroke thrombectomy aspiration system JET 7 Reperfusion Catheter with XTRA FLEX technology, a device that generates the vacuum necessary to suck out thrombi from within the brain.

Market Overview

The global Neurology Devices market size was worth $ YY billion in 2018 and is forecasted to reach $ YY billion by 2026, at a CAGR of YY% during the forecast period. Neurological devices can help diagnose, prevent, and treat a variety of neurological disorders and conditions such as Alzheimer’s disease, Parkinson’s disease, major depression, epilepsy, spinal cord injury, and traumatic brain injury. The demand for neurological devices that are used in treating such disorders has seen an upward growth trend with the introduction of new technological devices. For instance, in July 2019, EVER Pharma, a specialist in neurological diseases, introduced a complete therapy package for Parkinson’s disease with D-mine® Pump, D-mine® Pen and Dacepton® (Dopaceptin®, Apomorphine hydrochloride).

Market Dynamics

The neurology devices market growth is driven by the rising prevalence of chronic CNS disorders, globally aging population and increased adoption of minimally invasive neurological.

The growth of the global neurology devices market is attributed to the increasing incidence of neurological disorders that include brain aneurysms, brain tumors, epilepsy, memory disorders, multiple sclerosis, Parkinson’s disease, peripheral neuropathy, post-herpetic neuralgia, spinal cord tumor, and stroke. According to Alzheimer’s Disease International, globally, nearly 44 million people have Alzheimer’s or related dementia and is the most common in Western Europe.

Parkinson’s disease is the second most common age-related neurodegenerative disorder after Alzheimer’s disease. An estimated seven to 10 million people worldwide have Parkinson’s disease. Its prevalence ranges from 41 people per 100,000 in the fourth decade of life to more than 1,900 people per 100,000 among those who are 80 and older. According to the Brain Aneurysm Foundation, it is estimated that around 6 million people in the U.S. alone have an unruptured brain aneurysm and the annual rate of rupture is approximately 8 to 10 per 10,000 or about 30,000 people in the U.S. suffer an aneurysm rupture. According to the Epilepsy Society, there are around 60 million people with epilepsy in the world.  According to the American Cancer Society, an estimate for brain and spinal cord tumors in the United States in 2019 is roughly 23,820 malignant tumors of the brain or spinal cord (13,410 in males and 10,410 in females) will be diagnosed.

However, the high cost of neurology devices might hamper the global neurology device market. According to PriceGuide service, the average cost of the stimulators is $16,957, up 8% from 2016. The newer models, which are manufactured by Boston Scientific Corp. and Medtronic, cost on average $19,000. The cost of neurology endoscopes ranges from $1,75,000 to $2,25,000, based on the configuration.

Global Neurology Devices Market Segment Analysis

Based on product type, the global neurology devices market is segmented into Neurostimulation, Interventional Neurology, CSF Management Devices, Neurosurgery Devices, Others. Among these, neurostimulation devices accounted for the largest market share of more than 40% in 2018. Neurostimulation Devices is further sub-segmented into Spinal Cord Stimulation, Deep Brain Stimulation, Sacral Nerve Stimulation, Vagus Nerve Stimulation, and Gastric Electric-Stimulation devices. The neurostimulation devices help in reducing pain by blocking the pain signals before they reach the brain. Some of the key factors driving the market growth include growing geriatric population base, the introduction of novel technological advancements, escalating demand for neurostimulation devices as an add on therapy, increasing incidence of chronic diseases such as migraine and epilepsy and the presence of high unmet medical needs in these disease segments. New product launches along with an increased focus on R&D are other ways the leading players improve their market presence. For instance, In February 2019, LivaNova  Plc announced that the U.S. Centers for Medicare & Medicaid Services (CMS) finalized its National Coverage Determination (NCD) for the LivaNova vagus nerve stimulation therapy (VNS Therapy) System for treatment-resistant depression (TRD).

 

 

 

 

 

Geographical Analysis

North America is dominating the global Neurology Devices market in 2018 and estimated to hold the largest market size over the forecast period (2019-2026) owing to the presence of favorable government initiatives on neurological R&D investment and cancer research. The U.S holds about 70% of the market share of the North America neurology devices market in 2018.  The increasing regulatory approval for neurology devices in the U.S. is boosting the North America neurology devices market. For instance, in August 2018, Abbott received the U.S. Food and Drug Administration (FDA) approval for the Infinity DBS system. Infinity Deep Brain Stimulation (DBS) System designed to treat patients with Parkinson’s disease and essential tremors.

 

Besides, the sophisticated healthcare infrastructure in countries such as Canada and the U.S., and the presence of a considerably large CNS disorder patient base are some drivers anticipated to fuel demand in the region. According to the Alzheimer’s Association, 1 in 10 Americans over the age of 65 has Alzheimer’s. More than 5 million Americans are living with Alzheimer’s and by 2050, it’s estimated there will be as many as 16 million Americans living with Alzheimer’s.

 

 

 

 

 

The Neurology devices market is a highly consolidated market, with major shared obtained by most of the emerging and local players. Some of the major players include Helius Medical Technologies, Inc., Nihon Kohden Corporation, Neurotrope, Inc., Integra LifeSciences, and Eyecarrot Innovations Corp. Helius Medical Technologies is in surge with the PoNS device which is used for the treatment of neurological symptoms caused by brain diseases.

The key players are adopting various key strategies such as product launches, mergers, and acquisitions which are contributing to the growth of the neurology devices market globally. For instance,

In May 2019, Cala Health raised $50M ahead of the commercial launch of its bioelectric stimulation device.

In March 2019, Brainlab acquired Medineering, a developer of application-specific robotic technologies to expand digital surgery with scalable solutions. This will increase the depth of the Brainlab’s portfolio in cranial surgery and strengthens its offering in spinal surgery, contributing a powerful digital step in clinical workflows.

 

In February 2019, Medtronic PLC announced both the U.S. launch of Deep Brain Stimulation (DBS) for medically-refractory epilepsy and the first commercially implanted patient at Emory University in Atlanta. DBS therapy for epilepsy delivers controlled electrical pulses to a target in the brain called the anterior nucleus of the thalamus (ANT), which is part of a network involved in seizures.

Why Purchase the Report?

  • Visualize the composition of the Neurology Devices in terms of various types of neurology devices highlighting the key commercial assets and players.

  • Identify commercial opportunities in the Neurology Devices market by analyzing trends and co-development deals. 

  • Excel data sheet with thousands of data points of the Neurology Devices market-level 4/5 segmentation.

  • A PDF report with the most relevant analysis cogently put together after exhaustive qualitative interviews and in-depth market study.

  • Product mapping in excel for the key product of all major market players

Target Audience

  • Service Providers/ Buyers

  • Industry Investors/Investment Bankers

  • Education & Research Institutes

  • Research Professionals

  • Emerging Companies

  • Manufacturers   

 

Related Reports:

Dermatology Devices Market

Arthroscopy Devices Market

 

 

Table of Contents

  1. Global Neurology Devices Market Methodology and Scope

    1. Research Methodology

    2. Research Objective and Scope of the Report

  2. Global Neurology Devices Market – Market Definition and Overview

  3. Global Neurology Devices Market – Executive Summary

    1. Market Snippet by Product

  4. Global Neurology Devices Market Dynamics

    1. Market Impacting Factors

      1. Drivers

        1. The rise in the Incidence of Neurological Disorders and Aging Population

        2. Increasing regulatory approval for neurology devices

        3. Increasing investment for R&D activities

      2. Restraints

        1. The high cost of neurology devices

        2. Lack of awareness of neurological disorders

      3. Opportunity

      4. Impact Analysis

  5. Global Neurology Devices Market – Industry Analysis

    1. Porter's Five Forces Analysis

    2. Regulatory Analysis

    3. Supply Chain Analysis

    4. Pricing Analysis

  6. Global Neurology Devices Market – By Product

    1. Introduction

      1. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product Segment

      2. Market Attractiveness Index, By Product Segment

    2. Cerebrospinal Fluid Management Devices*

      1. Cerebral Shunts*

        1. Introduction

        2. Market Size Analysis, US$ Mn, 2016-2025 and Y-o-Y Growth Analysis (%), 2018-2026

      2. Cerebral External Drainage

    3. Neurostimulation Devices

      1. Implantable Devices

        1. Vagus Nerve Stimulators

        2. Spinal Cord Stimulators

        3. Deep Brain Stimulators

        4. Gastric Electric Stimulators

        5. Others

      2. External Devices

        1. Transcranial Magnetic Stimulation (TMS)

        2. Transcutaneous Electrical Nerve Stimulation (TENS)

        3. Others

    4. Interventional Neurology

      1. Aneurysm Coiling and Embolization

        1. Embolic Coils

        2. Flow Diversion Devices

        3. Liquid Embolic Reagents

      2. Neurovascular Catheters

        1. Micro Catheters

        2. Micro Guidewires

      3. Cerebral Balloon Angioplasty &Stents

        1. Carotid Artery Stents

        2. Filter Devices

        3. Balloon Occlusion Devices

      4. Neurothromobectomy

        1. Clot Retrievers

        2. Suction Aspiration Devices

        3. Snare Devices

    5. Neurosurgery Devices

      1. Ultrasonic Aspirators

      2. Stereotactic Systems

      3. Neuroendoscopes

      4. Aneurysm Clips

    6. Others

  7. Global Neurology Devices Market – By Region

    1. Introduction

      1. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Region

      2. Market Attractiveness Index, By Region

    2. North America

      1. Introduction

      2. Key Region-Specific Dynamics

      3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product

      4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country

        1. The U.S.

        2. Canada

        3. Mexico

    3. Europe

      1. Introduction

      2. Key Region-Specific Dynamics

      3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product

      4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country

        1. Germany

        2. The U.K.

        3. France

        4. Italy

        5. Spain

        6. Rest of Europe

    4. South America

      1. Introduction

      2. Key Region-Specific Dynamics

      3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product

      4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country

        1. Brazil

        2. Argentina

        3. Rest of South America

    5. Asia Pacific

      1. Introduction

      2. Key Region-Specific Dynamics

      3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product

      4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country

        1. China

        2. India

        3. Japan

        4. Australia

        5. Rest of Asia Pacific

    6. The Middle East and Africa

      1. Introduction

      2. Key Region-Specific Dynamics

      3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product

  8. Global Neurology Devices Market – Competitive Landscape

    1. Competitive Scenario

    2. Market Positioning/Share Analysis

    3. Mergers and Acquisitions Analysis

  9. Company Profiles

    1. Stryker Corporation*

      1. Company Overview

      2. Product Portfolio and Description

      3. Key Highlights

      4. Financial Overview

    2. Boston Scientific Corporation

    3. Integra LifeSciences Holdings Corporation

    4. Johnson and Johnson

    5. Medtronic Inc.

    6. Penumbra Inc.

    7. Abbott Laboratories

    8. Nihon Kohden Corporation

    9. Smith & Nephew plc

    10. B. Braun Melsungen AG

  10. Global Neurology Devices Market – Premium Insights

  11. Global Neurology Devices Market – DataM

    1. Appendix

    2. About Us and Services

    3. Contact Us

List of Tables& Figures

List of Tables

Table 1 Global Neurology Devices Market Value, By Product, 2018,2022 & 2026 ($ Million)

Table 2 Global Neurology Devices Market Value, By Region, 2018,2022 & 2026 ($ Million)

Table 3 Global Neurology Devices Market Value, By Product, 2018,2022 & 2026 ($ Million)

Table 4 Global Neurology Devices Market Value, By Product, 2017-2026 ($ Million)

Table 5 Global Neurology Devices Market Value, By Region, 2018,2022 & 2026 ($ Million)

Table 6 Global Neurology Devices Market Value, By Region, 2017-2026 ($ Million)

Table 7 North America Neurology Devices Market Value, By Product, 2017-2026 ($ Million)

Table 8 North America Neurology Devices Market Value, By Country, 2017-2026 ($ Million)

Table 9 South America Neurology Devices Market Value, By Product, 2017-2026 ($ Million)

Table 10 South America Neurology Devices Market Value, By Country, 2017-2026 ($ Million)

Table 11 Europe Neurology Devices Market Value, By Product, 2017-2026 ($ Million)

Table 12 Europe Neurology Devices Market Value, By Country, 2017-2026 ($ Million)

Table 13 Asia-Pacific Neurology Devices Market Value, By Product, 2017-2026 ($ Million)

Table 14 Asia-Pacific Neurology Devices Market Value, By Country, 2017-2026 ($ Million)

Table 15 the Middle East & Africa Neurology Devices Market Value, By Product, 2017-2026 ($ Million)

Table 16 Stryker Corportaion: Overview

Table 17 Stryker Corportaion: Product Portfolio

Table 18 Stryker Corportaion: Key Developments

Table 19 Boston Scientific Corporation: Overview

Table 20 Boston Scientific Corporation: Product Portfolio

Table 21 Boston Scientific Corporation: Key Developments

Table 22 Integra LifeSciences Holdings Corporation: Overview

Table 23 Integra LifeSciences Holdings Corporation: Product Portfolio

Table 24 Integra LifeSciences Holdings Corporation: Key Developments

Table 25 Johnson and Johnson: Overview

Table 26 Johnson and Johnson: Product Portfolio

Table 27 Johnson and Johnson: Key Developments

Table 28 Medtronic Inc.: Overview

Table 29 Medtronic Inc.: Product Portfolio

Table 30 Medtronic Inc.: Key Developments

Table 31 Penumbra Inc.: Overview

Table 32 Penumbra Inc.: Product Portfolio

Table 33 Penumbra Inc.: Key Developments

Table 34 Abbott Laboratories: Overview

Table 35 Abbott Laboratories: Product Portfolio

Table 36 Abbott Laboratories: Key Developments

Table 37 Nihon Kohden Corporation: Overview

Table 38 Nihon Kohden Corporation: Product Portfolio

Table 39 Nihon Kohden Corporation: Key Developments

Table 40 Smith & Nephew plc: Overview

Table 41 Smith & Nephew plc: Product Portfolio

Table 42 Smith & Nephew plc: Key Developments

Table 43 B. Braun Melsungen AG: Overview

Table 44 B. Braun Melsungen AG: Product Portfolio

Table 45 B. Braun Melsungen AG: Key Developments

 

List of Figures

Figure 1 Global Neurology Devices Market Share, By Product, 2018 & 2026 (%)

Figure 2 Global Neurology Devices Market Share, By Region, 2018 & 2026 (%)

Figure 3 Global Neurology Devices Market Value, 2017-2026 ($ Million)

Figure 4 Global Neurology Devices Market Y-o-Y Growth, By Product, 2018-2026 (%)

Figure 5 Cerebrospinal Fluid Management Devices: Global Neurology Devices Market Value, 2017-2026 ($ Million)

Figure 6 Neurostimulation Devices: Global Neurology Devices Market Value, 2017-2026 ($ Million)

Figure 7 Interventional Neurology: Global Neurology Devices Market Value, 2017-2026 ($ Million)

Figure 8 Neurosurgery Devices: Global Neurology Devices Market Value, 2017-2026 ($ Million)

Figure 9 Others: Global Neurology Devices Market Value, 2017-2026 ($ Million)

Figure 10 Global Neurology Devices Market Y-o-Y Growth, By Region, 2018-2026 (%)

Figure 11 North America Neurology Devices Market Value, 2017-2026 ($ Million)

Figure 12 North America Neurology Devices Market Share, By Product, 2018 & 2026 (%)

Figure 13 North America Neurology Devices Market Share, By Country, 2018 & 2026 (%)

Figure 14 South America Neurology Devices Market Value, 2017-2026 ($ Million)

Figure 15 South America Neurology Devices Market Share, By Product, 2018 & 2026 (%)

Figure 16 South America Neurology Devices Market Share, By Country, 2018 & 2026 (%)

Figure 17 Europe Neurology Devices Market Value, 2017-2026 ($ Million)

Figure 18 Europe Neurology Devices Market Share, By Product, 2018 & 2026 (%)

Figure 19 Europe Neurology Devices Market Share, By Country, 2018 & 2026 (%)

Figure 20 Asia-Pacific Neurology Devices Market Value, 2017-2026 ($ Million)

Figure 21 Asia-Pacific Neurology Devices Market Share, By Product, 2018 & 2026 (%)

Figure 22 Asia-Pacific Neurology Devices Market Share, By Country, 2018 & 2026 (%)

Figure 23 the Middle East & Africa Neurology Devices Market Value, 2017-2026 ($ Million)

Figure 24 the Middle East & Africa Neurology Devices Market Share, By Product, 2018 & 2026 (%)

Figure 25 Stryker Corporation: Financials

Figure 26 Boston Scientific Corporation: Financials

Figure 27 Integra LifeSciences Holdings Corporation: Financials

Figure 28 Johnson and Johnson: Financials

Figure 29 Medtronic Inc.: Financials

Figure 30 Penumbra Inc.: Financials

Figure 31 Abbott Laboratories: Financials

Figure 32 Nihon Kohden Corporation: Financials

Figure 33 Smith & Nephew plc: Financials

Figure 34 B. Braun Melsungen AG: Financials

Did not find what you were looking for?Every 7 out of 10 customers request tailored reports. Get yours today!
We collate your requirements.
Our global research team is put into action.
We deliver, and make sure your endeavour is a success!

Buy This Report



Get your FREE SAMPLE PROPOSAL with a single click!